Yang Xiaohong - the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 14 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Pyrotinib in Combination with Letrozole for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer (PLEHERM): a Multicenter, Single-Arm, Phase II Trial

Zhe-Yu Hu,Min Yan,Huihua Xiong,Li Ran,Jincai Zhong,Ting Luo,Tao Sun,Ning Xie,Liping Liu,Xiaohong Yang,Huawu Xiao,Jing Li,Binliang Liu,Quchang Ouyang

BMC MEDICINEno. 1 (2023)

Cited5Views0WOSBibtex

Eribulin Mesylate Versus Eribulin Plus Anlotinib in Patients with Advanced or Metastatic Breast Cancer: Results of a Phase II Study

Liping Liu,Zhe-Yu Hu,Ning Xie,Xiaohong Yang,Huawu Xiao,Jing Li,Can Tian,Hui Wu,Jun Lu,Jianxiang Gao,Xuming Hu,Min Cao,Zhengrong Shui, Bingliang Liu,Quchang Ouyang

JOURNAL OF CLINICAL ONCOLOGY（2022）

Cited2Views0Bibtex

Abstract PS13-17: Capecitabine Maintaining Treatment Improves Progression-Free Survival in Metastatic Breast Cancer: A Prospective Observational Study of 669 Cases

Quchang Ouyang,Zhe-Yu Hu,Xiaohong Yang,Liping Liu,Jing Li,Huawu Xiao,Jianxiang Gao,Jun Lu,Hui Wu,Ning Xie,Xuming Hu,Can Tian,Zhengrong Shui,Min Cao

Cancer Researchno. 4_Supplement (2021): PS13-17

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn